Eva Vivian

2.9k total citations · 2 hit papers
37 papers, 2.1k citations indexed

About

Eva Vivian is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Eva Vivian has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Geriatrics and Gerontology. Recurrent topics in Eva Vivian's work include Diabetes Management and Research (13 papers), Diabetes Treatment and Management (11 papers) and Diabetes Management and Education (8 papers). Eva Vivian is often cited by papers focused on Diabetes Management and Research (13 papers), Diabetes Treatment and Management (11 papers) and Diabetes Management and Education (8 papers). Eva Vivian collaborates with scholars based in United States, France and Israel. Eva Vivian's co-authors include Linda M. Siminerio, Joan K. Bardsley, Paulina Duker, Marjorie Cypress, Amy Hess Fischl, Martha M. Funnell, Melinda D. Maryniuk, Margaret A. Powers, Deborah P. Wubben and Mark B. Powers and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Clinical Therapeutics.

In The Last Decade

Eva Vivian

35 papers receiving 2.0k citations

Hit Papers

Diabetes Self-management Education and Support in Type 2 ... 2015 2026 2018 2022 2015 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Vivian United States 16 1.4k 639 573 375 276 37 2.1k
Johan Wens Belgium 28 1.8k 1.3× 1.1k 1.7× 922 1.6× 238 0.6× 360 1.3× 103 3.2k
Imad M. El‐Kebbi United States 26 2.1k 1.5× 569 0.9× 529 0.9× 208 0.6× 292 1.1× 38 3.4k
Mary K. Rhee United States 22 1.5k 1.1× 400 0.6× 360 0.6× 83 0.2× 155 0.6× 51 2.2k
Linda A. Jaber United States 22 924 0.7× 286 0.4× 218 0.4× 171 0.5× 92 0.3× 51 2.0k
Neda Laiteerapong United States 25 1.2k 0.9× 381 0.6× 492 0.9× 117 0.3× 67 0.2× 106 2.4k
Joan K. Bardsley United States 15 1.7k 1.2× 789 1.2× 750 1.3× 62 0.2× 81 0.3× 26 2.3k
Leonard Feldman United States 18 728 0.5× 198 0.3× 587 1.0× 108 0.3× 141 0.5× 64 2.4k
Lisa Kroon United States 18 482 0.3× 262 0.4× 552 1.0× 163 0.4× 90 0.3× 37 1.6k
Jay Desai United States 21 635 0.4× 324 0.5× 366 0.6× 60 0.2× 68 0.2× 59 1.5k
Tracey H. Taveira United States 20 457 0.3× 290 0.5× 173 0.3× 247 0.7× 120 0.4× 41 1.2k

Countries citing papers authored by Eva Vivian

Since Specialization
Citations

This map shows the geographic impact of Eva Vivian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Vivian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Vivian more than expected).

Fields of papers citing papers by Eva Vivian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Vivian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Vivian. The network helps show where Eva Vivian may publish in the future.

Co-authorship network of co-authors of Eva Vivian

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Vivian. A scholar is included among the top collaborators of Eva Vivian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Vivian. Eva Vivian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vivian, Eva & Constance A. Flanagan. (2022). Peers empowering peers-feasibility of a peer educator training program to prevent diabetes. BMC Women s Health. 22(1). 65–65.
2.
Bradley, John S., et al.. (2017). Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(3). 361–378. 21 indexed citations
3.
Vivian, Eva, et al.. (2016). Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR. Diabetes Metabolic Syndrome and Obesity. 9. 25–25. 11 indexed citations
4.
Powers, Mark B., Joan K. Bardsley, Marjorie Cypress, et al.. (2015). Diabetes Self-Management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Journal of the Academy of Nutrition and Dietetics. 115(8). 1323–1334. 214 indexed citations
5.
Vivian, Eva. (2014). Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents. Drugs in Context. 3. 1–19. 49 indexed citations
6.
Vivian, Eva, et al.. (2014). Identifying Knowledge Deficits of Food Insecure Patients with Diabetes. Current Diabetes Reviews. 10(6). 402–406. 9 indexed citations
7.
Vivian, Eva, et al.. (2013). Therapeutic approaches to slowing the progression of diabetic nephropathy – is less best?. SHILAP Revista de lepidopterología. 2013. 1–12. 14 indexed citations
8.
Vivian, Eva, et al.. (2012). Weight perceptions of parents with children at risk for diabetes. BMC Research Notes. 5(1). 47–47. 5 indexed citations
9.
Vivian, Eva, et al.. (2011). Identifying Children at Risk for Type 2 Diabetes in Underserved Communities. The Diabetes Educator. 37(4). 519–527. 6 indexed citations
10.
Svarstad, Bonnie L., Jane Morley Kotchen, Theresa I. Shireman, et al.. (2009). The Team Education and Adherence Monitoring (TEAM) Trial. Circulation Cardiovascular Quality and Outcomes. 2(3). 264–271. 24 indexed citations
11.
Wubben, Deborah P. & Eva Vivian. (2008). Effects of Pharmacist Outpatient Interventions on Adults with Diabetes Mellitus: A Systematic Review. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(4). 421–436. 218 indexed citations
12.
Klepser, Michael E., Gary R. Matzke, Eva Vivian, et al.. (2008). Ethical Issues Related to Clinical, Translational, and Health System Research. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(11). 1421–1421.
13.
Vivian, Eva. (2007). <b>The Pharmacist's Role in Maintaining Adherence to Insulin Therapy in Type 2 Diabetes Mellitus Clinical Review</b>. The Consultant Pharmacist. 22(4). 320–332. 11 indexed citations
14.
Vivian, Eva. (2006). Should Drug Therapy Be Personalized Based on Race?. Annals of Pharmacotherapy. 40(3). 550–552. 3 indexed citations
15.
Vivian, Eva, et al.. (2004). Insulin Strategies for Type 2 Diabetes Mellitus. Annals of Pharmacotherapy. 38(11). 1916–1923. 3 indexed citations
16.
Vivian, Eva, et al.. (2002). Pharmacologic management of diabetic nephropathy. Clinical Therapeutics. 24(11). 1741–1756. 22 indexed citations
17.
Vivian, Eva. (2002). Improving Blood Pressure Control in a Pharmacist‐Managed Hypertension Clinic. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(12). 1533–1540. 153 indexed citations
18.
Vivian, Eva, et al.. (2001). Slowing the Progression of Renal Disease in Diabetic Patients. Annals of Pharmacotherapy. 35(4). 452–463. 9 indexed citations
19.
Vivian, Eva, et al.. (2000). Pharmacologic strategies for treating gastroesophageal reflux disease. Clinical Therapeutics. 22(6). 654–672. 2 indexed citations
20.
Vivian, Eva, et al.. (1999). Efficacy and Cost Effectiveness of Lansoprazole Versus Omeprazole in Maintenance Treatment of Symptomatic Gastroesophageal Reflux Disease. The American Journal of Managed Care. 5(7). 881–886. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026